Welcome to SAfAIDS
SAfAIDS hosts a session on “Good Prison Health is Good Public Health-Domesticating the SADC Minimum Standards for Prisoners’ SRH Rights”
SAfAIDS Media, IAC, Durban 2016 Prisoners are an important group of society who must not be left behind if the world is serious in attaining its target to achieve 90 x 90 x 90 by 2020. This was emphasized by Dr. Vitalis Chipfakacha of the SADC Secretariat at a SAfAIDS Session at the International AIDS Conference currently underway in Durban, South Africa.
Today the 13th of July 2016, traditional and religious leaders in Marondera and Seke districts reaffirmed their commitment to reach the HIV fast track targets following a 2 day Community Capacity Building Indaba that was hosted by SAfAIDS in partnership with Seke Rural Home Based Care with technical and financial support from UNAIDS RST.
UNIVERSITY OF BARCELONA, 05 July 2016 (aidsmap) - People with undetectable viral load who switched from taking the Atripla single-tablet regimen (efavirenz/tenofovir/emtricitabine) every day to just every other weekday were able to maintain viral suppression for six months, and longer follow-up is planned, according to research presented last month at the ASM Microbe conference in Boston.
UK, 04 July 2016, (nat) - For many in HIV advocacy addressing stigma is the Holy Grail. Many, if not all, of the factors that drive the HIV epidemic are embroiled with stigma. The impact it has on the lives of people living with HIV is well documented. In a recent survey of over half of people living with HIV reported feelings of shame, guilt, low self-esteem and self-blame; one in five had experienced verbal harassment or threats.
ENGLAND, 04 July 2016 (bbcnews) - The NHS in England is introducing a "superior" test for cervical cancer, following a successful pilot programme.
Women in HIV serodiscordant relationships less likely to take PrEP consistently if they experience intimate partner violence
BOSTON, 30 June 2016 (aidsmap) - Experiencing intimate partner violence is associated with an increased risk of poor adherence to HIV pre-exposure prophylaxis (PrEP) among women in serodiscorant relationships in sub-Saharan Africa, investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Overall, 16% of women experienced intimate partner violence (IPV) and this increased the risk of suboptimal adherence to PrEP by 50%, when measured by either pill count or plasma tenofovir concentrations.